House Passes Bill To Hasten New Medical Treatments To Market

A bipartisan bill overwhelmingly passed by the U.S. House of Representatives Friday could permit some pharmaceutical companies to earn approval of new medicines and medical devices on the basis of smaller and shorter trials or by pointing to observational evidence not previously considered scientifically robust. Advocates say their legislation, passed by a 344-77 vote, would bring new lifesaving treatments to patients more cheaply and quickly. But opponents charge the measure would...
Read more: http://ift.tt/1KVZUmq